ストックスクリーナーアプリを入手
12.75
3.26%
-0.43
アフターアワーズ：
13.25
0.50
+3.92%
前日終値:
$13.18
開ける：
$13.18
24時間の取引高:
4.85M
Relative Volume:
2.69
時価総額：
$1.86B
収益：
$340.81M
当期純損益:
$-419.65M
株価収益率:
-4.4737
EPS:
-2.85
ネットキャッシュフロー:
$-402.10M
1週間 パフォーマンス:
-10.15%
1か月 パフォーマンス:
-13.88%
6か月 パフォーマンス:
-13.97%
1年 パフォーマンス:
-58.94%
1日の値動き範囲:
$12.72
$13.38
1週間の範囲:
$12.72
$14.37
52週間の値動き範囲:
$10.57
$33.33
Denali Therapeutics Inc Stock (DNLI) Company Profile
名前
Denali Therapeutics Inc
セクター
電話
(650) 866-8547
住所
161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO
DNLI を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
DNLI
Denali Therapeutics Inc
|
12.75 | 1.93B | 340.81M | -419.65M | -402.10M | -2.85 |
|
VRTX
Vertex Pharmaceuticals Inc
|
383.12 | 99.25B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
591.99 | 63.46B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.56 | 59.27B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
736.76 | 44.78B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
334.40 | 37.75B | 3.81B | -644.79M | -669.77M | -6.24 |
Denali Therapeutics Inc Stock (DNLI) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-04-10 | アップグレード | Cantor Fitzgerald | Neutral → Overweight |
| 2025-03-07 | 再開されました | Morgan Stanley | Overweight |
| 2025-02-11 | 開始されました | Deutsche Bank | Buy |
| 2025-01-07 | 開始されました | Robert W. Baird | Outperform |
| 2025-01-03 | 開始されました | William Blair | Outperform |
| 2024-12-16 | アップグレード | Stifel | Hold → Buy |
| 2024-10-10 | 再開されました | Raymond James | Mkt Perform |
| 2024-10-07 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2023-12-13 | 開始されました | Citigroup | Buy |
| 2023-11-20 | 再開されました | JP Morgan | Overweight |
| 2023-10-24 | 再開されました | Cantor Fitzgerald | Overweight |
| 2023-09-06 | 開始されました | B. Riley Securities | Buy |
| 2023-01-30 | 開始されました | SVB Securities | Outperform |
| 2022-12-05 | 開始されました | Cowen | Outperform |
| 2022-11-02 | アップグレード | BTIG Research | Neutral → Buy |
| 2022-11-02 | 開始されました | BofA Securities | Buy |
| 2022-06-23 | 開始されました | Berenberg | Buy |
| 2021-12-10 | 再開されました | Raymond James | Mkt Perform |
| 2021-09-21 | 開始されました | Oppenheimer | Outperform |
| 2021-09-01 | 開始されました | SMBC Nikko | Outperform |
| 2021-05-18 | 開始されました | UBS | Buy |
| 2021-02-26 | 繰り返されました | H.C. Wainwright | Buy |
| 2021-02-10 | アップグレード | Cantor Fitzgerald | Neutral → Overweight |
| 2020-11-11 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-10-16 | ダウングレード | BTIG Research | Buy → Neutral |
| 2020-09-14 | 再開されました | JP Morgan | Overweight |
| 2020-08-20 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-03-13 | アップグレード | Evercore ISI | In-line → Outperform |
| 2020-02-28 | アップグレード | Wedbush | Neutral → Outperform |
| 2020-02-24 | 開始されました | Jefferies | Buy |
| 2020-02-19 | 開始されました | Stifel | Hold |
| 2020-01-27 | アップグレード | Goldman | Neutral → Buy |
| 2019-09-26 | 開始されました | Wedbush | Neutral |
| 2019-09-13 | 開始されました | Nomura | Buy |
| 2019-08-09 | 開始されました | BTIG Research | Buy |
| 2019-06-26 | 開始されました | H.C. Wainwright | Buy |
| 2018-11-15 | 開始されました | Cantor Fitzgerald | Overweight |
| 2018-11-12 | 開始されました | Janney | Buy |
| 2018-03-12 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2018-01-02 | 開始されました | Evercore ISI | Outperform |
| 2018-01-02 | 開始されました | Goldman | Neutral |
| 2018-01-02 | 開始されました | JP Morgan | Overweight |
| 2018-01-02 | 開始されました | Morgan Stanley | Overweight |
すべてを表示
Denali Therapeutics Inc (DNLI) 最新ニュース
Analysts Set Denali Therapeutics Inc. (NASDAQ:DNLI) Target Price at $33.50 - MarketBeat
Aug Weekly: What’s the outlook for Denali Therapeutics Inc.’s sectorJuly 2025 Setups & Accurate Technical Buy Alerts - khodrobank.com
Can Denali Therapeutics Inc deliver consistent EPS growthJuly 2025 Trends & Scalable Portfolio Growth Ideas - khodrobank.com
Denali Therapeutics (NASDAQ:DNLI) Shares Down 4.5%Here's What Happened - MarketBeat
Aug Gainers: Why is Denali Therapeutics Inc stock going downJuly 2025 Reactions & Verified Entry Point Detection - khodrobank.com
TT International Asset Management LTD Invests $909,000 in Denali Therapeutics Inc. $DNLI - MarketBeat
Denali Therapeutics Inc. $DNLI Shares Acquired by UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC - MarketBeat
Denali Therapeutics Inc. $DNLI Shares Purchased by Millennium Management LLC - MarketBeat
When is the best time to exit Denali Therapeutics Inc.Weekly Volume Report & Weekly Chart Analysis and Guides - newser.com
Denali Therapeutics Inc. (DNLI) Secures FDA Priority Review for First-Ever Brain-Penetrant Hunter Syndrome Therapy - MSN
Street Watch: What are analysts price targets for Denali Therapeutics IncChart Signals & Free Expert Approved Momentum Trade Ideas - khodrobank.com
Denali Starts Dosing in Phase II Parkinson's Disease Study - MSN
Gainers Report: Is Denali Therapeutics Inc a turnaround storyChart Signals & Reliable Breakout Forecasts - خودرو بانک
Short Squeeze: Can GXAI deliver consistent dividendsEarnings Trend Report & Verified Short-Term Plans - خودرو بانک
Guidance Update: Should I invest in Denali Therapeutics Inc before earningsJuly 2025 PostEarnings & Intraday High Probability Setup Alerts - خودرو بانک
SCS Capital Management LLC Takes Position in Denali Therapeutics Inc. $DNLI - MarketBeat
Guidance Update: Is Denali Therapeutics Inc forming a bullish divergenceJuly 2025 Final Week & Community Consensus Trade Signals - خودرو بانک
Patterns Watch: Does Denali Therapeutics Inc have strong EBITDA marginsDollar Strength & Real-Time Sentiment Analysis - khodrobank.com
Signal Recap: Can Denali Therapeutics Inc. keep up with sector leaders2025 Major Catalysts & Safe Capital Allocation Plans - khodrobank.com
Dip Buying: Does BlackRock Income Trust Inc. have declining or rising EPSChart Signals & Free Reliable Trade Execution Plans - khodrobank.com
Aug Big Picture: How much upside does NRIM haveTrade Entry Report & Fast Entry High Yield Tips - خودرو بانک
Alliancebernstein L.P. Has $42.88 Million Position in Denali Therapeutics Inc. $DNLI - MarketBeat
UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Buys 3,184,042 Shares of Denali Therapeutics Inc. $DNLI - Defense World
Polar Asset Management Partners Inc. Has $285,000 Stock Holdings in Denali Therapeutics Inc. $DNLI - MarketBeat
Denali Therapeutics (NASDAQ:DNLI) Given "Overweight" Rating at Cantor Fitzgerald - MarketBeat
Yiheng Capital Management L.P. Sells 230,117 Shares of Denali Therapeutics Inc. $DNLI - MarketBeat
Denali Therapeutics Inc. $DNLI Shares Purchased by Graham Capital Management L.P. - MarketBeat
Denali Therapeutics Inc. $DNLI Shares Purchased by Trexquant Investment LP - MarketBeat
Why Is Denali Therapeutics (DNLI) Up 16.2% Since Last Earnings Report? - Yahoo Finance
Will Denali Therapeutics Inc. stock go up in YEARWeekly Investment Recap & Weekly Momentum Picks - Lancaster City Council
Crestline Management LP Has $56.57 Million Stock Position in Denali Therapeutics Inc. $DNLI - MarketBeat
Cantor Fitzgerald reiterates Overweight rating on Denali Therapeutics stock By Investing.com - Investing.com Canada
Cantor Fitzgerald reiterates Overweight rating on Denali Therapeutics stock - Investing.com
How cyclical is Denali Therapeutics Inc.’s revenue streamMarket Rally & Fast Moving Market Watchlists - beatles.ru
Should I hold or sell Denali Therapeutics Inc. nowPortfolio Value Summary & Stock Market Timing Techniques - beatles.ru
Denali Therapeutics Inc (DNLI) 財務データ
収益
当期純利益
現金流量
EPS
1.43%
0.09%
大文字化:
|
ボリューム (24 時間):